As the field of inflammation-driven cancer (e.g. colorectal cancer) gains momentum we speculate that IFNγ regulation of E-cadherin and associated signalling molecules, such as beta-catenin, is worthy of substantive investigation and has the potential to yield key insights into the regulation of the malignancy. The gene discussed is CTNNB1; the disease is cancer.